Category Health/Medical

Metformin, a widely prescribed, safe and inexpensive drug for type 2 diabetes, is a first-line treatment that lowers blood sugar and improves the body’s response to insulin. The drug appears to trick cells into sensing an energy shortage, similar to what happens during fasting or dieting. This activates a key cellular energy sensor called AMPK, which helps trigger cellular waste cleanup and supports cellular repair. Now, a recent review suggests metformin might also help counter some effects of aging.

The researchers compiled decades of global research, from cellular and molecular studies to animal and human studies, to provide a comprehensive, unified picture of how metformin might affect aging and longevity...

The neuroactive potential of bacteria living in the human gut is associated with levels of key chemicals in the brain, according to a new study published in Molecular Psychiatry. The research team from the University of Surrey and the University of Roehampton found that microbial pathways involved in producing and breaking down neuroactive compounds were associated with levels of GABA and glutamate in specific regions of the human brain.

GABA and glutamate are two of the brain’s most important chemical messengers. GABA predominantly dampens neural activity, while glutamate promotes excitation...

The U.S. Food and Drug Administration (FDA) on Tuesday authorized the first wearable sensor that continuously tracks ketones—chemicals the body makes when it burns fat instead of sugar for fuel.

It is also the first device anywhere to monitor ketones and blood sugar at the same time, the FDA said.

When ketones climb too high, they can cause diabetic ketoacidosis, or DKA. The American Diabetes Association warns that DKA can worsen within hours and lead to coma or death if it goes untreated.

Hospital admissions for DKA have risen 55% over the past decade, according to Abbott, which makes the device.

Early symptoms are often mistaken for a stomach bug or another common infection, which delays care. Most people also do not keep a blood ketone meter at home.

“Knowing that ...

Results from an early-stage clinical trial, published in Nature Communications, showed encouraging outcomes among patients with newly diagnosed cancer whose tumors had spread to distant organs. Most strikingly, one patient experienced a pathologic complete response—meaning no viable cancer cells could be found—and remains cancerfree for more than two years without further treatment. These findings offer an important signal that a new approach may be able to overcome one of the disease’s greatest challenges: its resistance to immunotherapy.

“We desperately need new tools in our arsenal,” said Gulam Manji, MD, PhD, a medical oncologist specializing in pancreatic cancer and lead investigator of the trial...